Ireland: CRH recorded a 2% year-on-year increase in sales to US$35.6bn in 2024, with net income rising by 15% to US$3.5bn during the period. The producer's earnings before interest, taxation, depreciation and amortisation (EBITDA) grew by 12% year-on-year to US$6.9bn.
In the fourth quarter of 2024, the company's sales rose by 2% year-on-year to US$8.9bn, while its net income increased by 24% to US$700m and its EBITDA by 12% to US$1.8bn.
CRH invested US$5bn in mergers and acquisitions during 2024. It maintains a positive outlook for the 2025 financial year, forecasting a net income of US$3.7 – US$4.1bn and an EBITDA of US$7.3 – US$7.7bn.
